mTOR-inhibitors and post-transplant diabetes mellitus: a link still debated in kidney transplantation.

Granata, Simona; Mercuri, Silvia; Troise, Dario; Gesualdo, Loreto; Stallone, Giovanni; Zaza, Gianluigi

Granata, Simona; Mercuri, Silvia; Troise, Dario; Gesualdo, Loreto; Stallone, Giovanni; Zaza, Gianluigi.

Afiliación

Granata S; Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Mercuri S; Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Troise D; Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Gesualdo L; Renal, Dialysis and Transplantation Unit, Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari, Bari, Italy.
Stallone G; Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Zaza G; Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.

Front Med (Lausanne) ; 10: 1168967, 2023.

Article en En | MEDLINE | ID: mdl-37250653

Palabras clave

allograft co-morbidities; immunosuppressive drugs; kidney transplantation; mTOR-inhibitor; post-transplant diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Med (Lausanne) Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google